Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination. - Wikidata - wikimedia - TriplyDB

Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.

Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.

http://www.wikidata.org/entity/Q37357786

about

Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Rethinking cancer nanotheranostics.Cell-Engineered Nanovesicle as a Surrogate Inducer of Contact-Dependent Stimuli.Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy

P2860

Q38912004-D1A586F3-94AA-4E05-94E2-A97512162DBC Q42640884-B8556F55-327E-4661-B29C-C658076AD813 Q47992337-6DD45853-9D77-4665-B3C9-AE6A0D7F1630 Q48974238-D5D64B1E-6843-45ED-BC48-7D293FEE85BE Q51068276-E34D6356-4B1E-438B-9595-304886F32D4F Q55085319-5C4F07B7-D097-4AEE-AC9C-0016B27E551C Q58792025-ADA90569-A5E1-4E74-95FE-5B9F5CD5F448

P2860

Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination.

http://www.wikidata.org/entity/Q37357786

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@en

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@nl

type

label

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@en

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@nl

prefLabel

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@en

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@nl

P1433

Q37357786-4ED55AC8-5504-43CD-B1CB-3C35EF6D2905

P1476

Q37357786-2E3C45D2-C358-44EC-9438-E10CFACD9AA7

P2093

Q37357786-6D36F31A-5EC2-4F93-B7D4-419A46E1AF50

Q37357786-AEF5B6FF-9AA1-4ECA-9AD1-2451909DB7BA

Q37357786-DE8C34D7-82F5-41D2-A278-362EF8D27391

P2860

Q37357786-012300B7-E742-41E5-89C8-49E75A52ACC9

Q37357786-073033D1-2FDA-4AEE-8C2F-F189A2E88F6B

Q37357786-08314B69-1E71-4D16-BB69-6DD4104CE143

Q37357786-0916DFD3-7332-41E3-9053-906A44DF94E9

Q37357786-0D3E9819-DCF1-4814-BE93-11C57631D2C6

Q37357786-136F505D-CE74-4A6E-8D49-66AA82EB3AD6

Q37357786-202AAA5D-6095-41BA-BACB-79E3520C74D0

Q37357786-2480D838-173B-4BBD-9DEF-D3C3EB9B6870

Q37357786-24E11879-8F6C-4269-876A-2B38D859400A

Q37357786-31653DB4-AC7C-443A-A03A-A861D213F180

P304

Q37357786-C9F951BC-D4E6-42BD-ACA7-F9F8D5672852

P31

Q37357786-328128FD-B9CA-4922-A619-071BFE93CEAD

P356

Q37357786-0E36F8D7-919C-40EA-B1FE-3176BAB8F447

P433

Q37357786-7178D395-5E1F-4ACF-8653-E0DBB3C17760

P478

Q37357786-BB98EF38-6F9F-4817-8C97-3956AC90C933

P50

Q37357786-24A8B8EF-2910-436F-9455-5AC6A9992609

Q37357786-5A77D1EF-7548-4DFD-91C7-9395F6F7BB49

P577

Q37357786-50E4FCC5-004A-4DB3-A974-3BD927F85D70

P698

Q37357786-0D78812A-F719-49E8-AAC0-02CAE464B012

P932

Q37357786-0303A266-26C6-4A43-836B-D38B1620C6F5

P356

P1433

P1476

Adjuvant-Loaded Subcellular Ve ...... Cells for Cancer Vaccination.

@en

P2093

Alexander G Stafford

http://www.w3.org/2001/XMLSchema#string

Maartje M C Bastings

http://www.w3.org/2001/XMLSchema#string

Sandeep T Koshy

http://www.w3.org/2001/XMLSchema#string

P2860

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.

Database of T cell-defined human tumor antigens: the 2013 update

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Tumor cell lysates as immunogenic sources for cancer vaccine design

Immunosuppressive strategies that are mediated by tumor cells

Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions

Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists

Comparison of immature and mature bone marrow-derived dendritic cells by atomic force microscopy

Neoantigens in cancer immunotherapy.

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.

P304

2321-2333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SMLL.201600061

http://www.w3.org/2001/XMLSchema#string

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Alexander S Cheung

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26953489

http://www.w3.org/2001/XMLSchema#string

P932

5074529

http://www.w3.org/2001/XMLSchema#string